This control plane turns synthetic pharmacovigilance exports into one review surface: case completeness, seriousness assessment, MedDRA coding, follow-up closure, aggregate reporting evidence, and named signal actions before committee decisions harden around weak packets.
Safety teams need one board where intake completeness, medical seriousness review, MedDRA coding, follow-up closure, aggregate reporting evidence, and named signal actions stay readable together.
This follows the Kinetic Gain pattern: routing, evidence, approvals, and operator-safe remediation posture for review-critical safety workflows.
The free surface proves the operator model; the commercial path is an embedded safety-signal router for regulated pharmacovigilance teams.